Andreas Poschenrieder
Impact in
- Oncology top 10%
- Chemokine receptors and signaling
- Peptidase Inhibition and Analysis
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
Papers in
- Oncology 7
- Chemokine receptors and signaling 5
- Peptidase Inhibition and Analysis 3
-
- Advanced biosensing and bioanalysis techniques 2
- Advanced Biosensing Techniques and Applications 2
- Co-authors
- Julie A. Stenken (1 shared paper)Margret Schottelius (9 shared papers)Hans‐Jürgen Wester (7 shared papers)Markus Schwaiger (6 shared papers)Theresa Osl (6 shared papers)Andreas K. Buck (3 shared papers)Andreas Schirbel (3 shared papers)Ulrich Keller (2 shared papers)
- Journals
- Journal of Nuclear Medicine (2 papers)EJNMMI Research (2 papers)Journal of Clinical Oncology (1 paper)Tomography (1 paper)Scientific Reports (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Andreas Poschenrieder
13 papers receiving 744 citations
Peers
Comparison fields: 5 of 97
- Oncology 302
- Radiology, Nuclear Medicine and Imaging 208
- Immunology 155
- Hematology 81
- Immunology and Allergy 23
Countries citing papers authored by Andreas Poschenrieder
This map shows the geographic impact of Andreas Poschenrieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Poschenrieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Poschenrieder more than expected).
Fields of papers citing papers by Andreas Poschenrieder
This network shows the impact of papers produced by Andreas Poschenrieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Poschenrieder. The network helps show where Andreas Poschenrieder may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Poschenrieder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 240 | |
| 2 | 2015 | 194 | |
| 3 | 2017 | 93 | |
| 4 | 2016 | 88 | |
| 5 | 2016 | 32 | |
| 6 | 2019 | 28 | |
| 7 | 2016 | 27 | |
| 8 | 2016 | 19 | |
| 9 | 2017 | 10 | |
| 10 | 2015 | 10 | |
| 11 | 2022 | 4 | |
| 12 | First in man experience of CXCR4-directed endoradiotherapy with 177Lu- and 90Y-labelled Pentixather in multiple myeloma patients | 2015 | 3 |
| 13 | 2022 | 1 |
About Andreas Poschenrieder
Andreas Poschenrieder is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Hematology and Biomedical Engineering, having authored 13 papers that have together received 749 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (5 papers), Peptidase Inhibition and Analysis (3 papers), Multiple Myeloma Research and Treatments (3 papers), Biosensors and Analytical Detection (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Advanced Biosensing Techniques and Applications (2 papers) and Radiomics and Machine Learning in Medical Imaging (1 paper). The work is most often cited by research in Oncology (302 citations), Radiology, Nuclear Medicine and Imaging (208 citations), Immunology (155 citations), Hematology (81 citations) and Immunology and Allergy (23 citations). Andreas Poschenrieder has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Julie A. Stenken, Margret Schottelius, Hans‐Jürgen Wester, Markus Schwaiger, Theresa Osl, Andreas K. Buck, Andreas Schirbel, Ulrich Keller, Michael Laßmann and Saskia Kropf. Their work appears in journals such as Journal of Nuclear Medicine, EJNMMI Research, Journal of Clinical Oncology, Tomography and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.